Literature DB >> 2107090

Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension.

J C Wanstall1, S R O'Donnell.   

Abstract

Contractile responses to endothelin, 5-hydroxytryptamine (5-HT), noradrenaline and potassium were obtained on isolated preparations of pulmonary artery from rats made pulmonary hypertensive by an injection of monocrotaline (105 mg/kg s.c.) 4 weeks previously. When compared with data obtained in control rats, the potencies (negative log EC50 values) for 5-HT, noradrenaline and potassium were increased (30, 3- and 3-fold, respectively), and the maximum contractions (mN/mm2) to endothelin, noradrenaline and potassium were reduced (65, 40 and 45% reduction). These changes were not seen 2 weeks after injection of monocrotaline, before pulmonary hypertension developed, or in preparations of aorta. It is concluded that monocrotaline-induced pulmonary hypertension affects pulmonary vascular responsiveness to spasmogens differentially. The comparative importance of endothelin and 5-HT as pulmonary vasoconstrictors may change in monocrotaline-induced pulmonary hypertension, there being an increase in responsiveness to 5-HT and a decrease in responsiveness to endothelin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107090     DOI: 10.1016/0014-2999(90)90524-a

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats.

Authors:  J C Wanstall; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.

Authors:  M R MacLean; G Sweeney; M Baird; K M McCulloch; M Houslay; I Morecroft
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.

Authors:  H Nakazawa; M Hori; H Ozaki; H Karaki
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone.

Authors:  Graeme A Deuchar; Andrew Docherty; Margaret R MacLean; Martin N Hicks
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  S-nitrosocaptopril: in vitro characterization of pulmonary vascular effects in rats.

Authors:  Debbie Y Y Tsui; Agatha Gambino; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Effects of atrial natriuretic peptide and nitroprusside on isolated pulmonary resistance and conduit arteries from rats with pulmonary hypertension.

Authors:  J C Wanstall; J S Thompson; A H Morice
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Evidence that nitric oxide from the endothelium attenuates inherent tone in isolated pulmonary arteries from rats with hypoxic pulmonary hypertension.

Authors:  J C Wanstall; I E Hughes; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia.

Authors:  Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

9.  Reduced relaxant potency of nitroprusside on pulmonary artery preparations taken from rats during the development of hypoxic pulmonary hypertension.

Authors:  J C Wanstall; I E Hughes; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.